NSG-S mice for acute myeloid leukemia, yes. For myelodysplastic syndrome, no

Por Griessinger, Emmanuel, Andreeff, Michael
Publicado no Haematologica (2018)

Concise manual of hematology and oncology

Por Berger, Dietmar P., Andreeff, Michael.
Publicado em 2008

Eradication of CML stem cells

Por Carter, Bing Z., Andreeff, Michael
Publicado no Oncoscience (2016)

Mitochondrial uncoupling and the Warburg effect: Molecular basis for the reprogramming of cancer cell metabolism

Por Samudio, Ismael, Fiegl, Michael, Andreeff, Michael
Publicado em 2009

Pharmacological activation of wild-type p53 in the therapy of leukemia

Por Kojima, Kensuke, Ishizawa, Jo, Andreeff, Michael
Publicado no Exp Hematol (2016)

Targeting autophagy to overcome chemoresistance in acute myleogenous leukemia

Por Piya, Sujan, Andreeff, Michael, Borthakur, Gautam
Publicado no Autophagy (2016)

Fatty Acid Metabolism, Bone Marrow Adipocytes, and AML

Por Tabe, Yoko, Konopleva, Marina, Andreeff, Michael
Publicado no Front Oncol (2020)

Indole-3-carbinol suppresses NF-κB and IκBα kinase activation, causing inhibition of expression of NF-κB-regulated antiapoptotic and metastatic gene products and enhancement of apo...

Por Takada, Yasunari, Andreeff, Michael, Aggarwal, Bharat B.
Publicado em 2005

Effects of PPARγ Ligands on Leukemia

Por Tabe, Yoko, Konopleva, Marina, Andreeff, Michael, Ohsaka, Akimichi
Publicado em 2012

Therapeutic targeting of microenvironmental interactions in leukemia: mechanisms and approaches

Por Konopleva, Marina, Tabe, Yoko, Zeng, Zhihong, Andreeff, Michael
Publicado em 2009

Apoptosis in Leukemias: Regulation and Therapeutic Targeting

Por Samudio, Ismael, Konopleva, Marina, Carter, Bing, Andreeff, Michael
Publicado em 2010

Bone marrow niche-mediated survival of leukemia stem cells in acute myeloid leukemia: Yin and Yang

Por Zhou, Hong-Sheng, Carter, Bing Z., Andreeff, Michael
Publicado no Cancer Biol Med (2016)

Osteogenic niche in the regulation of normal hematopoiesis and leukemogenesis

Por Le, Phuong M., Andreeff, Michael, Battula, Venkata Lokesh
Publicado no Haematologica (2018)

1,25-dihydroxyvitamin D(3) enhances the apoptotic activity of MDM2 antagonist nutlin-3a in acute myeloid leukemia cells expressing wild-type p53

Por Thompson, Thelma, Andreeff, Michael, Studzinski, George P., Vassilev, Lyubomir T.
Publicado em 2010

The novel tryptamine derivative JNJ-26854165 induces wild-type p53- and E2F1-mediated apoptosis in acute myeloid and lymphoid leukemias

Por Kojima, Kensuke, Burks, Jared K., Arts, Janine, Andreeff, Michael
Publicado em 2010

Preclinical antileukemic activity, toxicology, toxicokinetics and formulation development of triptolide derivative MRx102

Por Fidler, John M., An, Jinhua, Cater, Bing Z., Andreeff, Michael
Publicado em 2014

Concomitant inhibition of Mdm2-p53 interaction and Aurora kinases activates the p53-dependent postmitotic checkpoints and synergistically induces p53-mediated mitochondrial apoptos...

Por Kojima, Kensuke, Konopleva, Marina, Tsao, Twee, Nakakuma, Hideki, Andreeff, Michael
Publicado em 2008

The CDK1 inhibitor RO-3306 enhances p53-mediated Bax activation and mitochondrial apoptosis in AML

Por Kojima, Kensuke, Shimanuki, Masaya, Shikami, Masato, Andreeff, Michael, Nakakuma, Hideki
Publicado em 2009

The elusive CML stem cell: does it matter and how do we eliminate it?

Por Carter, Bing Z., Mak, Duncan D., Cortes, Jorge, Andreeff, Michael
Publicado em 2010

Investigational FMS-Like Tyrosine Kinase 3 (FLT3) Inhibitors in Treatment of Acute Myeloid Leukemia (AML)

Por Pemmaraju, Naveen, Kantarjian, Hagop, Andreeff, Michael, Cortes, Jorge, Ravandi, Farhad
Publicado em 2014